Autoimmune diabetes

August 23, 2019
Published by admin_auro at August 23, 2019
Categories

Combinatorial therapy for autoimmune diabetes  (TIDM):   A pharmaceutical mixture encompassing Dulaglutide (trade name: Trulicity), a Glucagon-like peptide-1  (GLP-1) receptor agonist, and Verapamil (brand name: Calanm, Isoptin and others), an anti-hypertensive drug,  increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up-regulation of its target gene, 23/August/2019, 11.38 pm

Introduction: What they say A study from the International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, “L. Sacco” Department of Biomedical and […]
Do you like it?0
Read more
August 20, 2019
Published by admin_auro at August 20, 2019
Categories

Natural product-based curative therapy for autoimmune diabetes  (TIDM):  Repurposing the anti-malarial drug Artesunate into an anti-diabetic drug:  Artesunate, a derivative of Artimesinin, which aids in the treatment of malaria, increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up-regulation of its target gene, 20/August/2019, 10.09 pm

Introduction: What they say A study from the International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, “L. Sacco” Department of Biomedical and […]
Do you like it?0
Read more
July 5, 2019
Published by admin_auro at July 5, 2019
Categories

Curing autoimmune diabetes  (TIDM) with HDAC (Histone deacetylase) inhibitors: Givinostat/Gavinostat-based therapy for autoimmune diabetes:Givinostat/Gavinostat, a histone deacetylase inhibitor used to treat systemic juvenile idiopathic arthritis,polycythaemia vera., Duchenne muscular dystrophy and others, increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up-regulation of its target gene, 5/July/2019, 11.19 pm

Introduction: What they say A study from the International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, “L. Sacco” Department of Biomedical and […]
Do you like it?0
Read more
July 4, 2019
Published by admin_auro at July 4, 2019
Categories

Curing autoimmune diabetes  (TIDM) with interleukin 1 receptor antagonists:Anakinra-based therapy for autoimmune diabetes: Anakinra (brand name: Kineret and others),  an interleukin 1 receptor antagonist used in the treatment of rheumatoid arthritis, increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up-regulation of its target gene, 4/July/2019, 11.03 pm

Introduction: What they say A study from the International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, “L. Sacco” Department of Biomedical and […]
Do you like it?0
Read more
12345678910111213141516171819
Next page